Press releases 2025
2025-12-19 - Biotest announces US FDA approval of Grifols’ Fesilty
PDF, 140 KB
[ Download ]
2025-11-13 - Biotest obtains approval for new human fibrinogen Prufibry in Germany
PDF, 144 KB
[ Download ]
2025-11-07 - Biotest AG Extraordinary general meeting convened again at the request of Grifols S.A.
PDF, 93 KB
[ Download ]
2025-10-23 - Biotest AG Cancellation of the extraordinary general meeting on 28 October 2025
PDF, 91 KB
[ Download ]
2025-09-19 - Biotest AG Extraordinary general meeting convened at the request of Grifols S.A.
PDF, 43 KB
[ Download ]
2025-08-04 - Biotest AG receives a request from Grifols S.A. to convene an extraordinary general meeting
PDF, 95 KB
[ Download ]
2025-07-02 - Biotest AG Annual General Meeting approves dividend distribution
PDF, 128 KB
[ Download ]
2025-06-23 -Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
PDF, 153 KB
[ Download ]
2025-06-03 - Ad hoc - Biotest AG Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025
PDF, 83 KB
[ Download ]
2025-05-28 - Ad hoc - Change of the Chief Executive Officer (CEO) of Biotest AG
PDF, 80 KB
[ Download ]
2025-05-12 - Biotest confirms Guidance for 2025
PDF, 106 KB
[ Download ]
2025-03-31 - Biotest AG increases sales by 6% in financial year 2024
PDF, 138 KB
[ Download ]
2025-03-31 - Ad hoc - Biotest AG Delisting agreement and announced delisting tender offer
PDF, 84 KB
[ Download ]
2025-03-06 - Ad hoc - CFO Martin Moeller to leave Biotest as planned at the end of his contract
PDF, 124 KB
[ Download ]
2025-02-26 - Ad hoc - Biotest publishes preliminary business figures - 2024 forecasts partially exceeded
PDF, 84 KB
[ Download ]
2025-01-09 - Important milestone for Biotest - Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)
PDF, 146 KB
[ Download ]
Biotest Press releases 2024
2024-05-07 - Biotest AG Annual General Meeting approves dividend distribution
PDF, 142 KB
[ Download ]
2024-02-29 - Biotest achieves EBIT forecast for 2023
PDF, 95 KB
[ Download ]
2024-01-24 - Ad hoc - Biotest achieves EBIT forecast for 2023
PDF, 123 KB
[ Download ]
Biotest Press releases 2023
2023-09-07 - US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
PDF, 100 KB
[ Download ]
2023-02-09 - Ad hoc - Biotest significantly exceeds EBIT guidance 2022
PDF, 128 KB
[ Download ]